Tizoxanide Antiviral Activity on Dengue Virus Replication
Viruses · 07.03.2023 · 15 (3) · 696
DOI: 10.3390/v15030696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 07.03.2023. Verfasst von Kristie A Yamamoto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Institute of Chemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil. Hauptthemen laut MEDLINE: Dengue, Dengue Virus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation, North Carolina Agricultural Research Service, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (Originalsprache)
Dengue virus is an important circulating arbovirus in Brazil responsible for high morbidity and mortality worldwide, representing a huge economic and social burden, in addition to affecting public health. In this study, the biological activity, toxicity, and antiviral activity against dengue virus type 2 (DENV-2) of tizoxanide (TIZ) was evaluated in Vero cell culture. TIZ has a broad spectrum of action in inhibiting different pathogens, including bacteria, protozoa, and viruses. Cells were infected for 1 h with DENV-2 and then treated for 24 h with different concentrations of the drug. The quantification of viral production indicated the antiviral activity of TIZ. The protein profiles in infected Vero cells treated and not treated with TIZ were analyzed using the label-free quantitative proteomic approach. TIZ was able to inhibit virus replication mainly intracellularly after DENV-2 penetration and before the complete replication of the viral genome. Additionally, the study of the protein profile of infected not-treated and infected-treated Vero cells showed that TIZ interferes with cellular processes such as intracellular trafficking and vesicle-mediated transport and post-translational modifications when added after infection. Our results also point to the activation of immune response genes that would eventually lead to a decrease of DENV-2 production. TIZ is a promising therapeutic molecule for the treatment of DENV-2 infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Institute of Chemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.
- Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC 27607, USA.
- Institute of Pediatrics and Puericulture Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-912, Brazil.
- Department of Virology, Paulo de Góes Microbiology Institute, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
ORCID-Profile: Monica F Moreira, Marcia R Soares
Förderung
- National Science Foundation
- North Carolina Agricultural Research Service
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
Zitieren
APA
Yamamoto, K. A., Blackburn, K., Goshe, M. B., Brown, D. T., Migoswski, E., Campanhon, I. B., Moreira, M. F., Ferreira, D. F., & Soares, M. R. (2023). Tizoxanide Antiviral Activity on Dengue Virus Replication. Viruses, 15(3), 696. https://doi.org/10.3390/v15030696
Vancouver
Yamamoto KA, Blackburn K, Goshe MB, Brown DT, Migoswski E, Campanhon IB, et al. Tizoxanide Antiviral Activity on Dengue Virus Replication. Viruses. 2023;15(3):696. doi:10.3390/v15030696
BibTeX
@article{Yamamoto2023,
author = {Yamamoto, Kristie A and Blackburn, Kevin and Goshe, Michael B and Brown, Dennis T and Migoswski, Edimilson and Campanhon, Isabele B and Moreira, Monica F and Ferreira, Davis F and Soares, Marcia R},
title = {Tizoxanide Antiviral Activity on Dengue Virus Replication},
journal = {Viruses},
year = {2023},
volume = {15},
number = {3},
pages = {696},
doi = {10.3390/v15030696}
}
EUVIMED